OPNA BIO SA
4Patents
4Active
4Granted
59Portfolio score
Filing activity: Apr 22, 2021 → Oct 25, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11628176B2 | Combinational drug therapies | Human Necessities | 1 | Active |
| US11807626B2 | Compounds and methods for CD73 modulation and indications therefor | Chemistry; Metallurgy | 1 | Active |
| US12202818B2 | Compounds and methods for CD73 modulation and indications therefor | Chemistry; Metallurgy | 0 | Active |
| US12116365B2 | Heterocyclic compounds and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.